Livagen is a short bioregulatory peptide that has direct effects on DNA structure and function. It is best known for its ability to decondense chromatin, thereby increasing the expression of certain genes and improving the “youthful” profile of cells. Its most studied effects are on lymphocytes of the immune system. Through these cells, Livagen has been shown to activate the immune system and offset disease in the heart, GI tract, immune system, and central nervous system. Livagen research has also shown promise in the area of nociception and pain control. Ongoing research will help to further unravel the promise of Livagen and bring humanity closer to understanding the processes of aging and senescence.

Cartalax is a short bioregulatory peptide with widespread systemic impact due to its effects on fibroblasts. It has been shown to benefit skin and other connective tissues as well as the kidneys. Research shows that Cartalax increases cell proliferation rates and beneficially alters the levels of various cytokines and signaling molecules associated with senescence. Overall, it increases cell health and proliferation while decreasing cell death. Cartalax is thought of as an anti-aging peptide, returning older cells to a more youthful state and prolonging overall tissue health.

Vesugen is a bioregulator and geroprotective tripeptide. Research has shown it to protect the vascular system from the effects of aging by limiting the development of atherosclerosis and decreasing overall endothelial cell dysfunction. Systems that are sensitive to vascular damage and decline therefore show the most obvious effects from Vesugen administration. These systems include the central nervous system and cardiovascular system. Vesugen appears to play a prominent role in regulating sirtuin 1 protein levels. Sirtuin 1 has important effects on metabolic processes and helps to reduce the effects of aging. Sirtuin 1 is activated as a result of calorie restriction and is therefore thought to be one of the proteins responsible for the profound anti-aging effects associated with calorie restriction.

Pinealon is a synthetic peptide just three amino acids in length. It has been shown to modify behavior and protect a number of cell types against the effects of hypoxia. It has undergone extensive research for its ability to alter circadian rhythm, improve memory, and enhance learning. It has been shown to offset the effects of aging, particularly in the central nervous system, and may be useful in treating cognitive disorders like Alzheimer’s disease.

Pancragen is a naturally occurring tetrapeptide bioregulator that has primary effects on the pancreas. Pancragen research has shown it to help control blood sugar, improve endocrine function of the pancreas, regulate melatonin expression, and reduce the incidence and magnitude of metabolic syndrome. It has been researched and is of interest in the treatment of both diabetes and the metabolic effects of aging. Pancragen can be thought of as an anti-aging peptide for the pancreas.

Chonluten is a short peptide bioregulator of gene expression. Research has shown it to be most active in lung tissue with secondary levels of activity in the GI tract. It regulates genes related to inflammation and antioxidant activity as well as genes involved in proliferation responses to inflammation. Regulation of pulmonary mucosal function by Chonluten may have important applications in chronic inflammatory diseases of the lung such as asthma and COPD.

Cardiogen, is a bioregulator peptide which appears to have potent effects on multiple body tissues including the heart and prostate. Additionally, the peptide may be beneficial in the treatment of certain types of cancer, particularly sarcoma. Currently, the biggest benefits of cardiogen appear to be in the settings of heart attack, hypertension, and chronic heart failure where the peptide not only offers benefits of its own accord, but acts in a synergistic manner with established treatments.